FDA expands tamiflu use to treat babies under one year old

FDA expands tamiflu use to treat babies under 1 year old
Tamiflu can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.

(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.

Tamiflu can be used as treatment in children aged 2 weeks to 1 year if they have had for no longer than two days. The drug is not approved to prevent flu in these children and the safety and effectiveness of Tamiflu in children younger than 2 weeks of age has not been established.

While there are fixed dosing regimens for children 1 year and older according to weight categories, dosing for children younger than 1 year must be calculated individually based on exact weight, the FDA stressed. Children 2 weeks to 1 year of age should receive 3 milligrams per kilogram of weight twice daily for five days.

"Pharmacists must provide the proper dispenser when filling a prescription so parents can measure and administer the correct dose to their children," Edward Cox, M.D., M.P.H., director of the Office of in the FDA's Center for Drug Evaluation and Research, said in an FDA news release.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Tamiflu touted for child use

Nov 16, 2007

The maker of the anti-viral Tamiflu said the drug is effective for treatment and prevention of influenza in young children.

FDA panel backs infant doses for kids' Tylenol

May 18, 2011

(AP) -- Federal health experts say dosing instructions for children younger than 2 years old should be added to Children's Tylenol and similar products containing acetaminophen, the popular pain reliever and fever reducer.

FDA issues Tussionex safety alert

Mar 11, 2008

The U.S. Food and Drug Administration issued a safety alert, saying incorrect usage of a specific cough medicine can result in serious health risks.

Two pancreatic-enzyme products approved

Mar 02, 2012

(HealthDay) -- Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

13 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

cantdrive85
3 / 5 (4) Dec 22, 2012
The poisoning of our children continues...
PeterD
3.7 / 5 (3) Dec 23, 2012
The poisoning of our children continues...

You got that right. Tamiflu is completely worthless, and does nothing to benefit adults, let alone children. The FDA is a criminal organization that should be ended.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.